2-85666658-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_000542.5(SFTPB):c.352G>A(p.Asp118Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,613,776 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000542.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFTPB | NM_000542.5 | c.352G>A | p.Asp118Asn | missense_variant | 4/11 | ENST00000519937.7 | NP_000533.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFTPB | ENST00000519937.7 | c.352G>A | p.Asp118Asn | missense_variant | 4/11 | 1 | NM_000542.5 | ENSP00000428719.2 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 151984Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000211 AC: 53AN: 251384Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135868
GnomAD4 exome AF: 0.0000992 AC: 145AN: 1461674Hom.: 1 Cov.: 35 AF XY: 0.000110 AC XY: 80AN XY: 727146
GnomAD4 genome AF: 0.000184 AC: 28AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74360
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 14, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 130 of the SFTPB protein (p.Asp130Asn). This variant is present in population databases (rs45557339, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with SFTPB-related conditions. ClinVar contains an entry for this variant (Variation ID: 619287). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SFTPB protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Hereditary pulmonary alveolar proteinosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2023 | The c.388G>A (p.D130N) alteration is located in exon 5 (coding exon 4) of the SFTPB gene. This alteration results from a G to A substitution at nucleotide position 388, causing the aspartic acid (D) at amino acid position 130 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Surfactant metabolism dysfunction, pulmonary, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Feb 08, 2019 | SFTPB c.352G>A has not been reported in ClinVar nor the literature, to our knowledge. This variant (rs45557339) is rare in large population datasets (gnomAD: 68/282654 alleles; 0.02406%, no homozygotes). Two bioinformatic tools queried predict that this substitution would be tolerated, and the aspartic acid residue at this position is not evolutionarily conserved across species assessed. Due to insufficient evidence that this variant is deleterious, the clinical significance of c.352G>A is uncertain at this time. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at